China Grants Sabinsa Forskolin Solubility Patent

EAST WINDSOR, N.J.Sabinsa earned a Chinese patent for a process that makes the forskolin molecule 6000-times more water soluble. The State Intellectual Property Office of the Peoples Republic of China granted the patent titled, "Process for Preparing Water Soluble Diterpenes and Their Applications."  Sabinsa also holds patents on this process in the United States, Eurasia, India, Philippines, Mexico, New Zealand, Singapore, South Africa and Uzbekistan.

Aqueous formulation facilitates the safe and effective use of forskolin as a natural ophthalmic drug in the management of glaucoma (approved in India), as well as in dermatological and related applications," said Lakshmi Prakash, Sabinsa vice president of innovation and business development.   

Forskolin is an extract prepared from the herb Coleus forskohlii, a member of the mint family of plants that grows wild in some parts of India. In some areas people grow it and use the roots to make pickle. In recent years, Coleus forskohlii has gained importance as the only source of Forskolin, a bioactive molecule with multiple applications in health and wellness, made possible due largely to research initiatives by Sabinsa.

 This recent patent is the 66th in Sabinsas worldwide Intellectual Property portfolio. Additionally, Sabinsa has over 50 pending patent applications worldwide.

Sabinsa's mission is to provide alternative and complementary natural products for human nutrition and well-being. Over the past 20 years, Sabinsa has brought to market more than 100 standardized botanical extracts and privately funded several clinical studies in conjunction with prestigious institutions in support of these products. With more than 100 full-time scientists conducting ongoing research in India and the United States, Sabinsa continues to develop and patent phytonutrients for the world market. All products intended for human consumption are certified Kosher, with many certified Halal.